IR@PKUHSC  > 北京大学药学院
学科主题药学
Design, synthesis and biological characterization of novel inhibitors of CD38
Dong, Min1; Si, Yuan-Qi1; Sun, Shuang-Yong1; Pu, Xiao-Ping1; Yang, Zhen-Jun1; Zhang, Liang-Ren1; Zhang, Li-He1; Leung, Fung Ping2; Lam, Connie Mo Ching.2; Kwong, Anna Ka Yee2; Yue, Jianbo2; Zhou, Yeyun3; Kriksunov, Irina A.3; Hao, Quan2; Lee, Hon Cheung2
刊名ORGANIC & BIOMOLECULAR CHEMISTRY
2011
DOI10.1039/c0ob00768d
9期:9页:3246-3257
收录类别SCI ; IC
文章类型Article
WOS标题词Science & Technology
类目[WOS]Chemistry, Organic
研究领域[WOS]Chemistry
关键词[WOS]CYCLIC ADP-RIBOSE ; ADENINE-DINUCLEOTIDE ; CRYSTAL-STRUCTURE ; BASIC SCIENCE ; NAADP ; DIFFERENTIATION ; IDENTIFICATION ; GLYCOHYDROLASE ; STIMULATION ; CONTRACTION
英文摘要

Human CD38 is a novel multi-functional protein that acts not only as an antigen for B-lymphocyte activation, but also as an enzyme catalyzing the synthesis of a Ca(2+) messenger molecule, cyclic ADP-ribose, from NAD(+). It is well established that this novel Ca(2+) signaling enzyme is responsible for regulating a wide range of physiological functions. Based on the crystal structure of the CD38/NAD(+) complex, we synthesized a series of simplified N-substituted nicotinamide derivatives (Compound 1-14). A number of these compounds exhibited moderate inhibition of the NAD(+) utilizing activity of CD38, with Compound 4 showing the highest potency. The crystal structure of CD38/Compound 4 complex and computer simulation of Compound 7 docking to CD38 show a significant role of the nicotinamide moiety and the distal aromatic group of the compounds for substrate recognition by the active site of CD38. Biologically, we showed that both Compounds 4 and 7 effectively relaxed the agonist-induced contraction of muscle preparations from rats and guinea pigs. This study is a rational design of inhibitors for CD38 that exhibit important physiological effects, and can serve as a model for future drug development.

语种英语
WOS记录号WOS:000289488000024
项目编号NSFC-RGC 20831160506 ; N_HKU 722/08 ; 769107 ; 768408 ; 769309 ; 770610 ; RR001646
资助机构National Natural Sciences Foundation of China ; NSFC/RGC ; General Research Fund of Hong Kong ; NIH
引用统计
被引频次:22[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/56063
专题北京大学药学院
北京大学药学院_药物化学系
北京大学药学院_分子与细胞药理学系
作者单位1.Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China
2.Univ Hong Kong, Dept Physiol, Hong Kong, Hong Kong, Peoples R China
3.Cornell Univ, Cornell High Energy Synchrotron Source, MacCHESS, Ithaca, NY 14853 USA
推荐引用方式
GB/T 7714
Dong, Min,Si, Yuan-Qi,Sun, Shuang-Yong,et al. Design, synthesis and biological characterization of novel inhibitors of CD38[J]. ORGANIC & BIOMOLECULAR CHEMISTRY,2011,9(9):3246-3257.
APA Dong, Min.,Si, Yuan-Qi.,Sun, Shuang-Yong.,Pu, Xiao-Ping.,Yang, Zhen-Jun.,...&Lee, Hon Cheung.(2011).Design, synthesis and biological characterization of novel inhibitors of CD38.ORGANIC & BIOMOLECULAR CHEMISTRY,9(9),3246-3257.
MLA Dong, Min,et al."Design, synthesis and biological characterization of novel inhibitors of CD38".ORGANIC & BIOMOLECULAR CHEMISTRY 9.9(2011):3246-3257.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Dong, Min]的文章
[Si, Yuan-Qi]的文章
[Sun, Shuang-Yong]的文章
百度学术
百度学术中相似的文章
[Dong, Min]的文章
[Si, Yuan-Qi]的文章
[Sun, Shuang-Yong]的文章
必应学术
必应学术中相似的文章
[Dong, Min]的文章
[Si, Yuan-Qi]的文章
[Sun, Shuang-Yong]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。